Calliditas Therapeutics Employee Directory

Calliditas Therapeutics corporate office is located in Kungsbron 1, Stockholm, Stockholm, 111 22, Sweden and has 201-500 employees.

Likely to Engage tag.Highly Engaged Employees

Employees by Department

Departments

Number of employees

Sales

30

Marketing

7

Medical & Health

5

Finance

2

C-Suite

2

Information Technology

1

Key Employees of Calliditas Therapeutics

  • KS
    Sweden flag for contact location.
    Kristine Solom...

    Commercial Business Controller (US)

    PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail

Calliditas Therapeutics Global Presence

globalPresence illustration
North America51-200
Europe51-200

Index of contact profiles from Calliditas Therapeutics

Hundreds of professionals searching for Calliditas Therapeutics have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
123

Former Employees at Calliditas Therapeutics

Explore people who held key positions, contributed to Calliditas Therapeutics's success, and advanced their careers.

People from Similar Companies in the Manufacturing Industry Located in Sweden

Frequently Asked Questions Regarding Calliditas Therapeutics Employees

How many employees does Calliditas Therapeutics have?
Calliditas Therapeutics has 201-500 employees
Who are Calliditas Therapeutics key employees?
Some of Calliditas Therapeutics key employees are Kristine Solomon
Where is Calliditas Therapeutics located?
Calliditas Therapeutics’s headquarters are located at Kungsbron 1, Stockholm, Stockholm, 111 22, Sweden
How do I contact Calliditas Therapeutics?
Calliditas Therapeutics Contact Info: Phone number: +46 84113005 Website: www.calliditas.se
What does Calliditas Therapeutics do?

Calliditas Therapeutics is a specialty pharmaceutical company based in Stockholm, Sweden. It is focused on developing high quality pharmaceutical products for patients with a significant unmet medical need in niche indications, in which the Company can partially or completely participate in the commercialization efforts. The Company is focused on t... he development and commercialization of the product candidate Nefecon, a unique two-step formulation optimized to combine a time lag effect with a concentrated release of the active substance budesonide, within a designated target area. This patented, locally acting formulation is intended for treatment of patients with the inflammatory renal disease IgA nephropathy (IgAN). Calliditas Therapeutics is running a global Phase 3 study within IgAN and aims to commercialize Nefecon in the US. The company is listed on Nasdaq Stockholm (ticker: CALTX).Read More

See more information about Calliditas Therapeutics Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.